4//SEC Filing
Kleijwegt Martijn 4
Accession 0001209191-18-027108
CIK 0001035354other
Filed
Apr 30, 8:00 PM ET
Accepted
May 1, 4:32 PM ET
Size
5.9 KB
Accession
0001209191-18-027108
Insider Transaction Report
Form 4
Kleijwegt Martijn
Director
Transactions
- Purchase
Common Stock
2018-04-30$9.75/sh+300,000$2,925,000→ 2,953,673 total(indirect: By LSP investment fund)
Footnotes (2)
- [F1]Reflects the purchase of shares in the follow-on offering of Common Stock of Eloxx Pharmaceuticals, Inc. that closed on April 30, 2018.
- [F2]Represents shares of the Issuer held by LSP V Cooperatieve U.A. ("LSP V"). LSP V Management B.V. ("LSP V Management") is the director and manager of LSP V. Mr. Kleijwegt is a Managing Director of LSP V Management. By virtue of this relationship, Mr. Kleijwegt may be deemed to share voting and dispositive power with respect to the shares held by LSP V. Mr. Kleijwegt disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise.
Documents
Issuer
Eloxx Pharmaceuticals, Inc.
CIK 0001035354
Entity typeother
Related Parties
1- filerCIK 0001726016
Filing Metadata
- Form type
- 4
- Filed
- Apr 30, 8:00 PM ET
- Accepted
- May 1, 4:32 PM ET
- Size
- 5.9 KB